drugset / Trial / NCT01661751

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003

NCT01661751 ↗

Phase 3 Completed 900 enrolled Hualan Biological Engineering, Inc.
RandomizedParallel-groupDouble-blindPrevention

Summary

The clinical trial was designed to evaluate the safety and immunogenicity against Group ACYW135 Meningococcal Polysaccharide Vaccine of Hualan administered on subjects 2 years of age and older.

Timeline

Start
2006-05
Primary completion
2006-05
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator A+C Meningococcal Polysaccharide Vaccine Vaccine 0.5 ml —
Subject ACYW135 Meningococcal Polysaccharide Vaccine Vaccine 0.5 ml —

Indications